Financials Riken Vitamin Co., Ltd.

Equities

4526

JP3972600005

Food Processing

Market Closed - Japan Exchange 02:00:00 2024-04-26 EDT 5-day change 1st Jan Change
2,708 JPY -0.26% Intraday chart for Riken Vitamin Co., Ltd. +0.48% +21.16%

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 57,533 71,848 44,761 55,011 63,097 82,203 - -
Enterprise Value (EV) 1 65,942 80,456 49,902 55,243 58,502 82,203 82,203 82,203
P/E ratio 21.9 x -2.92 x -27.7 x 2.55 x 9.84 x 9.67 x 11.3 x 10.5 x
Yield 2.31% 3.83% 3.08% 2.74% 3.07% 2.77% 2.95% 3.14%
Capitalization / Revenue 0.65 x 0.87 x 0.58 x 0.69 x 0.71 x 0.89 x 0.84 x 0.81 x
EV / Revenue 0.65 x 0.87 x 0.58 x 0.69 x 0.71 x 0.89 x 0.84 x 0.81 x
EV / EBITDA - - - - - - - -
EV / FCF 24,244,878 x 41,149,931 x 12,506,690 x 14,654,068 x 10,190,105 x - - -
FCF Yield 0% 0% 0% 0% 0% - - -
Price to Book 0.98 x 0.5 x 0.97 x 0.83 x 0.88 x - - -
Nbr of stocks (in thousands) 32,782 32,792 32,792 32,803 32,812 30,356 - -
Reference price 2 1,755 2,191 1,365 1,677 1,923 2,708 2,708 2,708
Announcement Date 19-04-25 20-09-30 21-05-14 22-05-13 23-05-12 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 89,024 82,974 77,722 79,231 88,750 92,800 97,400 101,700
EBITDA - - - - - - - -
EBIT 1 4,580 5,307 1,367 5,840 7,158 9,200 9,900 10,600
Operating Margin 5.14% 6.4% 1.76% 7.37% 8.07% 9.91% 10.16% 10.42%
Earnings before Tax (EBT) 1 6,044 -6,979 -7 20,313 7,857 10,000 10,500 11,200
Net income 1 2,623 -8,933 -1,618 21,582 6,414 8,500 7,300 7,800
Net margin 2.95% -10.77% -2.08% 27.24% 7.23% 9.16% 7.49% 7.67%
EPS 2 80.04 -751.4 -49.36 658.0 195.5 280.0 240.5 257.0
Free Cash Flow 2,373 1,746 3,579 3,754 6,192 - - -
FCF margin 2.67% 2.1% 4.6% 4.74% 6.98% - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 90.47% - - 17.39% 96.54% - - -
Dividend per Share 2 40.50 84.00 42.00 46.00 59.00 75.00 80.00 85.00
Announcement Date 19-04-25 20-09-30 21-05-14 22-05-13 23-05-12 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 37,960 38,603 20,983 21,569 43,631 23,672 22,189 44,613 24,445
EBITDA - - - - - - - - -
EBIT 1 -495 2,396 2,154 2,023 3,557 2,409 2,476 4,596 3,064
Operating Margin -1.3% 6.21% 10.27% 9.38% 8.15% 10.18% 11.16% 10.3% 12.53%
Earnings before Tax (EBT) 1 -2,281 14,469 2,628 2,430 4,225 2,358 2,961 5,181 3,272
Net income 1 -2,858 17,162 2,550 1,833 3,146 1,745 2,068 3,667 2,413
Net margin -7.53% 44.46% 12.15% 8.5% 7.21% 7.37% 9.32% 8.22% 9.87%
EPS 2 -87.18 523.3 77.69 55.90 95.90 53.22 63.05 111.7 73.52
Dividend per Share 21.00 21.00 - - 23.00 - - 30.50 -
Announcement Date 20-11-16 21-11-11 22-02-10 22-08-10 22-11-11 23-02-10 23-08-10 23-11-10 24-02-09
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 8,409 8,608 5,141 232 - - - -
Net Cash position - - - - 4,595 - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 2,373 1,746 3,579 3,754 6,192 - - -
ROE (net income / shareholders' equity) 4.5% -17% - 38.3% 9.3% - - -
ROA (Net income/ Total Assets) 4.35% 5.68% 1.59% 5.91% 7.43% - - -
Assets 1 60,335 -157,347 -102,050 365,160 86,324 - - -
Book Value Per Share 1,792 4,393 1,407 2,028 2,174 - - -
Cash Flow per Share 199.0 -297.0 71.30 772.0 309.0 - - -
Capex 4,316 4,104 4,046 3,069 1,643 - - -
Capex / Sales 4.85% 4.95% 5.21% 3.87% 1.85% - - -
Announcement Date 19-04-25 20-09-30 21-05-14 22-05-13 23-05-12 - - -
1JPY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 4526 Stock
  4. Financials Riken Vitamin Co., Ltd.